History of Sexual Violence in Higher Education

In this chapter, we describe the history of sexual violence as it pertains to postsecondary institutions, focusing on social movements, research, and policy, and their implications for higher education

The morbidity of urethral stricture disease among male Medicare beneficiaries

<p>Abstract</p> <p>Background</p> <p>To date, the morbidity of urethral stricture disease among American men has not been analyzed using national datasets. We sought to analyze the morbidity of urethral stricture disease by measuring the rates of urinary tract infections and urinary incontinence among men with a diagnosis of urethral stricture.</p> <p>Methods</p> <p>We analyzed Medicare claims data for 1992, 1995, 1998, and 2001 to estimate the rate of dual diagnoses of urethral stricture with urinary tract infection and with urinary incontinence occurring in the same year among a 5% sample of beneficiaries. Male Medicare beneficiaries receiving co-incident ICD-9 codes indicating diagnoses of urethral stricture and either urinary tract infection or urinary incontinence within the same year were counted.</p> <p>Results</p> <p>The percentage of male patients with a diagnosis of urethral stricture who also were diagnosed with a urinary tract infection was 42% in 2001, an increase from 35% in 1992. Eleven percent of male Medicare beneficiaries with urethral stricture disease in 2001 were diagnosed with urinary incontinence in the same year. This represents an increase from 8% in 1992.</p> <p>Conclusions</p> <p>Among male Medicare beneficiaries diagnosed with urethral stricture disease in 2001, 42% were also diagnosed with a urinary tract infection, and 11% with incontinence. Although the overall incidence of stricture disease decreased over this time period, these rates of dual diagnoses increased from 1992 to 2001. Our findings shed light into the health burden of stricture disease on American men. In order to decrease the morbidity of stricture disease, early definitive management of strictures is warranted.</p

Predictors of Implantable Pulse Generator Placement After Sacral Neuromodulation: Who Does Better?

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107552/1/ner12109.pd

Outcomes of Sacral Neuromodulation in a Privately Insured Population

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134200/1/ner12472_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134200/2/ner12472.pd

The Effect of Sacral Neuromodulation on Anticholinergic Use and Expenditures in a Privately Insured Population

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106102/1/ner12062.pd

Jupiter's visible aurora and Io footprint

Images obtained by the Galileo spacecraft's solid-state imaging (SSI) system represent the first survey of Jupiter's northern auroral emissions at visible wavelengths and on the nightside of the planet. These images captured the emissions with unprecedented spatial resolutions down to ∼26 km pixel^(−1). Four classes of emission were observed: (1) a continuous, primary arc associated with the middle/outer magnetosphere, (2) a variable secondary arc associated with the region just beyond Io's torus, (3) diffuse “polar cap” emission, and (4) a patch and tail associated with the magnetic footprint of Io. The primary arc emission occurs at an altitude 245±30 km above the 1-bar pressure level. Its horizontal width is typically a few hundred kilometers, and its total optical power output varied between ∼10^(10) and ∼10^(11) W in observations taken months apart. The location of the primary arc in planetary coordinates is similar to that on dayside images at other wavelengths and does not vary with local time. The morphology of the primary arc is not constant, changing from a multiply branched, latitudinally distributed pattern after dusk to a single, narrow arc before dawn. Emission from Io's ionospheric footprint is distinct from both the primary and secondary arcs. Measurements of its optical power output ranged from 2 to 7×10^8 W

Irradiation control of the "SPIRAL" target by measuring the ion beam intensity via a fast current transformer

International audienceIn order to obtain a more precise control on the irradiation of the targets of the "SPIRAL" installation, a new criterion of safety must be respected. To control this latter, an AQ system has been put in operation and more specifically a new device has been set up in order to measure the ion beam intensity and to calculate the number of particules per second. This value can then be integrated over time. This device consists of two Fast Current Transformers integrated in a mechanical unit placed in a vacuum chamber. These sensors reproduce the image of the pulsed beam at 10MHz and we take from the amplified signal of each sensor, the amplitude of the 2nd harmonic. Each one of these amplitudes is detected by a Lock-in Amplifier, which is acquired via a real time industrial controller. The intensity is calculated by the Fourier series relation between the amplitude of the 2nd harmonic and the average intensity. These equipments can be remotely tested by integrating a test turn on the sensors. They are redundant. The accuracy of measurement is estimated taking into account the variation of beam, of the environment and of the installatio

THI safety system

International audienceFor several years, GANIL has been allowed to reach a maximum beam power of six kilowatts (400W in normal mode) thanks to the THI system (High Intensity Transport System). Three modes of running are necessary to accelerate a THI beam ("Injector" mode, "tuning" mode and "surveillance" mode). The "surveillance" mode requires a safety system to protect equipment against beam losses. Inside cyclotrons, diagnostics measure beam-loss currents at the injection and extraction devices. Along beam lines, diaphragms measure beam-loss currents at the input and output of dipoles. Current transformers are used for beam transmission measurements through beam lines and the cyclotrons. The safety system controls beam losses and quickly cuts the beam with a chopper if losses exceed thresholds. These thresholds can be seen and changed by software

Resolution and enhancement in nanoantenna-based fluorescence microscopy

Single gold nanoparticles can act as nanoantennas for enhancing the fluorescence of emitters in their near-fields. Here we present experimental and theoretical studies of scanning antenna-based fluorescence microscopy as a function of the diameter of the gold nanoparticle. We examine the interplay between fluorescence enhancement and spatial resolution and discuss the requirements for deciphering single molecules in a dense sample. Resolutions better than 20 nm and fluorescence enhancement up to 30 times are demonstrated experimentally. By accounting for the tip shaft and the sample interface in finite-difference time-domain calculations, we explain why the measured fluorescence enhancements are higher in the presence of an interface than the values predicted for a homogeneous environment.Comment: 10 pages, 3 figures. accepted for publication in Nano Letter

PROSPECT guideline for total hip arthroplasty: a systematic review and procedure-specific postoperative pain management recommendations

The aim of this systematic review was to develop recommendations for the management of postoperative pain after primary elective total hip arthroplasty, updating the previous procedure-specific postoperative pain management (PROSPECT) guidelines published in 2005 and updated in July 2010. Randomised controlled trials and meta-analyses published between July 2010 and December 2019 assessing postoperative pain using analgesic, anaesthetic, surgical or other interventions were identified from MEDLINE, Embase and Cochrane databases. Five hundred and twenty studies were initially identified, of which 108 randomised trials and 21 meta-analyses met the inclusion criteria. Peri-operative interventions that improved postoperative pain include: paracetamol; cyclo-oxygenase-2-selective inhibitors; non-steroidal anti-inflammatory drugs; and intravenous dexamethasone. In addition, peripheral nerve blocks (femoral nerve block; lumbar plexus block; fascia iliaca block), single-shot local infiltration analgesia, intrathecal morphine and epidural analgesia also improved pain. Limited or inconsistent evidence was found for all other approaches evaluated. Surgical and anaesthetic techniques appear to have a minor impact on postoperative pain, and thus their choice should be based on criteria other than pain. In summary, the analgesic regimen for total hip arthroplasty should include pre-operative or intra-operative paracetamol and cyclo-oxygenase-2-selective inhibitors or non-steroidal anti-inflammatory drugs, continued postoperatively with opioids used as rescue analgesics. In addition, intra-operative intravenous dexamethasone 8-10 mg is recommended. Regional analgesic techniques such as fascia iliaca block or local infiltration analgesia are recommended, especially if there are contra-indications to basic analgesics and/or in patients with high expected postoperative pain. Epidural analgesia, femoral nerve block, lumbar plexus block and gabapentinoid administration are not recommended as the adverse effects outweigh the benefits. Although intrathecal morphine 0.1 mg can be used, the PROSPECT group emphasises the risks and side-effects associated with its use and provides evidence that adequate analgesia may be achieved with basic analgesics and regional techniques without intrathecal morphine